EUVIMEDEUVIMED entdecken
Crossref

Long-Term Outcomes after Ross-Operation in Children: Experience from the European ROSS Registry

NS. Pommert, I. Yemets, V. Voth, P. Murin, FA. Kari, J. Photiadis, T. Puehler, B. Fujita, D. Zimpfer, S. Ensminger

The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 01 S 01) · S1-S70

DOI: 10.1055/s-0046-1817335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von NS. Pommert und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

All articles of this category (opens in new window)

Background

The Ross operation represents a valuable treatment option in pediatric patients by using the living autologous pulmonary valve as a substitute for the diseased aortic valve. To date, experience with this demanding technique has mainly been reported as single-centre series or as small patient cohorts. This multicenter registry aims to evaluate long-term outcomes after Ross operation in children with regard to survival, autograft durability, and right ventricular outflow tract (RVOT) function.

Methods

We analyzed retrospective and prospective data from the ROSS Registry collected between 1988 and 2023 from 13 centers across five European countries. A total of 571 patients who underwent a Ross operation under 21 years of age were included, with a mean follow-up of 10 years and a maximum of 26 years.

Results

Most patients presented with congenital aortic valve disease, with 70% of valves being bicuspid. The mean age at surgery was 10.6 ± 6.5 years, and more than 50% of the patients had undergone prior cardiac surgery or intervention. Overall survival after Ross operation was 94.6%. The highest mortality was observed within the first 30 postoperative days (2.6%), with risk factors including age < 1 year, weight < 10 kg, NYHA class ≥ III, left ventricular ejection fraction < 50%, and additional nonaortic valve cardiac disease. Overall freedom from autograft reoperation was 91.9%, with most reoperations performed for aortic regurgitation secondary to root dilatation (60.9%) or structural valve deterioration (23.9%). In our analysis, surgical technique (full-root replacement [ n = 466, 82.0%] vs. subcoronary implantation [ n = 102, 18.0%]) had no significant impact on survival or autograft durability. Overall freedom from RVOT reoperation was 78.6%, primarily due to RVOT stenosis. Among RVOT substitutes, pulmonary homografts were associated with the lowest reoperation rates.

Conclusion

The Ross operation in children provides excellent long-term survival and autograft durability. RVOT reintervention, however, remains the Achilles’ heel of the procedure, accounting for the majority of late morbidity. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Pommert, N., Yemets, I., Voth, V., Murin, P., Kari, F., Photiadis, J., Puehler, T., Fujita, B., Zimpfer, D., & Ensminger, S. (2026). Long-Term Outcomes after Ross-Operation in Children: Experience from the European ROSS Registry. The Thoracic and Cardiovascular Surgeon, 74(S 01 S 01), S1-S70. https://doi.org/10.1055/s-0046-1817335

Vancouver

Pommert N, Yemets I, Voth V, Murin P, Kari F, Photiadis J, et al. Long-Term Outcomes after Ross-Operation in Children: Experience from the European ROSS Registry. The Thoracic and Cardiovascular Surgeon. 2026;74(S 01 S 01):S1-S70. doi:10.1055/s-0046-1817335

BibTeX
@article{Pommert2026,
  author = {Pommert, NS. and Yemets, I. and Voth, V. and Murin, P. and Kari, FA. and Photiadis, J. and Puehler, T. and Fujita, B. and Zimpfer, D. and Ensminger, S.},
  title = {Long-Term Outcomes after Ross-Operation in Children: Experience from the European ROSS Registry},
  journal = {The Thoracic and Cardiovascular Surgeon},
  year = {2026},
  volume = {74},
  number = {S 01 S 01},
  pages = {S1--S70},
  doi = {10.1055/s-0046-1817335}
}
Kostenlos starten →